InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Savacool Kristi A, Directeur Médical. Insider active across 1 company, notably TrueBlue, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €47k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Savacool Kristi A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
27,566 shares0Common StockSEC:0001332706-26-000002:0
18,111 shares0Common StockSEC:0000768899-25-000059:0
10,050 shares0Common StockSEC:0000768899-24-000045:0
4,550 shares@ US$10.98100.0% of flowCommon StockSEC:0000768899-23-000134:0
Canonical exit: 24 Jan 2024 (T+90)
7,116 shares0Common StockSEC:0000768899-23-000024:0
4,956 shares0Common StockSEC:0000768899-22-000033:0
6 of 6 declarations
About Savacool Kristi A
Debra Zack is the Chief Medical Officer at EXAGEN INC. In this role, she oversees the company's medical and scientific operations, ensuring the integrity of products and services. Debra is committed to promoting innovation and meeting patient needs.
